NCT03088098View on ClinicalTrials.gov

Comparison of Left Atrial Appendage Occlusion vs Standard Medical Therapy in Patients in AF Undergoing TAVI

NAActive, not recruitingINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

May 2, 2016

Primary Completion Date

September 14, 2024

Study Completion Date

September 14, 2024

Conditions

Atrial FibrillationAortic Stenosis

Interventions

DEVICE

LAAO

Left atrial appendage occlusion for stroke prevention

Trial Locations (1)

8091

University Hospital Zurich, Zurich

Sponsors

Collaborators (1)

Abbott Medical Devices

All Listed Sponsors

collaborator

Abbott Medical Devices

INDUSTRY

lead

University of Zurich

OTHER